Your browser doesn't support javascript.
loading
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
Surey, J; Stagg, H R; Yates, T A; Lipman, M; White, P J; Charlett, A; Muñoz, L; Gosce, L; Rangaka, M X; Francis, M; Hack, V; Kunst, H; Abubakar, I.
Afiliação
  • Surey J; Institute for Global Health, University College London, London, UK. j.surey@ucl.ac.uk.
  • Stagg HR; Faculty of Medicine, Universidad Autónoma Madrid, Madrid, Spain. j.surey@ucl.ac.uk.
  • Yates TA; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Lipman M; Institute for Global Health, University College London, London, UK.
  • White PJ; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, W2 1NY, UK.
  • Charlett A; UCL-TB and UCL Respiratory, UCL, London, Royal Free London National Health Service Foundation Trust, London, UK.
  • Muñoz L; National Infection Service, Public Health, England, UK.
  • Gosce L; Department of Infectious Disease Epidemiology, Imperial College School of Public Health, MRC Centre for Global Infectious Disease Analysis and NIHR Health Protection Research Unit in Modelling Methodology, London, UK.
  • Rangaka MX; National Infection Service, Public Health, England, UK.
  • Francis M; Clinical Sciences Department. School of Medicine, University of Barcelona and Internal Medicine Department, Parc Sanitari Sant Joan de Déu. Sant Boi, Barcelona, Spain.
  • Hack V; Institute for Global Health, University College London, London, UK.
  • Kunst H; Institute for Global Health, University College London, London, UK.
  • Abubakar I; Institute for Global Health, University College London, London, UK.
BMC Infect Dis ; 21(1): 90, 2021 Jan 21.
Article em En | MEDLINE | ID: mdl-33478428
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Latente / Antituberculosos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Latente / Antituberculosos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article